Overview

Good Solution: An increase in insured US citizens will stimulate industry demand

IBISWorld’s Intravenous (IV) Solution Manufacturing Industry Research Report offers insight into the market at the national level. Our analysis highlights macro trends in the overall sector and the micro trends faced by companies that do business in the Intravenous (IV) Solution Manufacturing industry. Our five-year outlook forecasts explain how the market is set to change and the product segments that will drive growth.

REPORT SNAPSHOT

Industry Threats & Opportunities

  • Consolidation has increased vertical integration and helped safeguard profit
  • Flu seasons result in a nationwide spike in normal saline consumption in hospitals, placing further strain on manufacturers
  • With more companies entering the industry, the number of employees will also continue to rise

  • shopping_cartBUY NOW TO READ MORE

    Industry Analysis & Industry Trends

    Whether for delivering anesthesia or nutrients, the Intravenous (IV) Solution Manufacturing industry provides hospitals with an array of IV solutions. Since the industry relies mainly on downstream demand from hospitals, the number of people with health insurance plays a critical role in determining demand for IV solutions. Forthcoming changes to the nation's healthcare system under the Patient Protection and Affordable Care Act of 2010 are anticipated to increase the number of insured Americans over the next five years. In turn, hospital demand is projected to rise and help support demand for IV solutions...

    shopping_cartBUY NOW TO READ MORE

    Industry Report - Industry Key Buyers Chapter

    The Intravenous Solution Manufacturing industry is categorized by a high level of market share concentration. The three largest operators in the industry alone account for 84.3% of total revenue. This high concentration is almost entirely attributed to the dominance of Baxter International in the industry with the company alone accounting for 43.5% of industry revenue. Further, concentration has only increased with higher consolidation activity, as noted by the number of enterprises declining in the industry. Notable merger and acquisition activity includes Baxter's purchase of Prism's Nexterone product portfolio and of privately held Baxa in 2012 and Pfizer's acquisition of Hospira in 2015.

    ..

    shopping_cartBUY NOW TO READ MORE

    Additional Insights for the Intravenous (IV) Solution Manufacturing Industry

    IBISWorld identifies 250 Key Success Factors for a business.The most important for the Intravenous (IV) Solution Manufacturing Industry are

  • Quickly adopt new technology
  • Close monitoring of competition
  • Must comply with government regulations
  • IBISWorld analysts also discuss how external factors such as Demand from hospitals and Total health expenditure in the Intravenous (IV) Solution Manufacturing industry impact industry performance..

    shopping_cartBUY NOW TO READ MORE

    Look under the hood?

    Download a FREE sample report

    Industry Products

    What is the Intravenous (IV) Solution Manufacturing Industry?

    Companies in this industry primarily engage in manufacturing substances that may be infused directly into a vein using a venous access device. Intravenous (IV) solutions may be used to correct electrolyte imbalances, to deliver medications, for blood transfusion or as fluid replacement. Solutions specifically for animals are excluded from this industry.

    Industry Products
    Crystalloids
    Colloids
    Blood products
    Oxygen-carrying solutions
    Industry Activities
    Manufacturing crystalloid solutions
    Manufacturing colloid solutions
    Manufacturing blood products
    Manufacturing oxygen-carrying products

    Table of Contents

    About this Industry
    Industry Definition
    Main Activities
    Similar Industries
    Additional Resources
    Industry at a Glance
    Industry Statistics Snapshot
    Industry Structure
    Executive Summary
    Industry Performance
    Executive Summary
    Key External Drivers
  • Demand from hospitals
  • Total health expenditure
  • Number of people with private health insurance
  • Price of plastic materials and resin
  • Trade-weighted index

  • Current Performance
  • Demand for hospital services and total health expenditure grows
  • Saline shortage
  • Profit and industry structure
  • Chart: Revenue Growth

  • Industry Outlook
  • Total health spending to grow as well
  • Profit and industry structure
  • Table: Intravenous (IV) Solution Manufacturing Industry Revenue Outlook

  • Industry Life Cycle
  • Life cycle reasons
  • Chart: Benchmarking - Intravenous (IV) Solution Manufacturing Industry Lifecycle vs The Economy

  • Products & Markets
    Supply Chains
    Key Buying Industries
  • Home Care Providers
  • Hospitals
  • Specialty Hospitals
  • Nursing Care Facilities

  • Key Selling Industries
  • Plastic & Resin Manufacturing

  • Products & Services
  • Crystalloids
  • Colloids
  • Blood products
  • Oxygen-carrying solutions
  • Chart: Intravenous (IV) Solution Manufacturing Industry Products and Services Segmentation

  • Demand Determinants
    Major Markets
  • Hospitals
  • Outpatient surgery centers
  • Exports
  • Homecare facilities
  • Other
  • Chart: Major Market Segmentation for the Intravenous (IV) Solution Manufacturing Industry

  • International Trade
    Business Locations
    Chart: Business Locations by State
    Competitive Landscape
    Market Share Concentration
    Key Success Factors
    Cost Structure Benchmarks
  • Profit
  • Purchases
  • Wages
  • Rent, utilities, depreciation and marketing
  • Other costs
  • Chart: Cost Structure Benchmarking – Sector vs Intravenous (IV) Solution Manufacturing

  • Basis of Competition
  • Internal Competition
  • External competition

  • Barriers to Entry
  • Table: Barrier to Entry Checklist for the Intravenous (IV) Solution Manufacturing Industry

  • Industry Globalization
    Major Companies
    Baxter International Inc.Hospira Inc.B. Braun Medical Inc.
  • Table: Baxter International Inc. - financial performance
  • Table: Hospira Inc. - financial performance
  • Table: B. Braun Medical Inc. - financial performance

  • Operating Conditions
    Capital Intensity
  • Chart: Level of Capital Intensity for the Intravenous (IV) Solution Manufacturing Industry
  • Chart: Tools of the Trade: Growth Strategies for Success

  • Technology & Systems
    Revenue Volatility
  • Chart: Volatility vs Industry Growth

  • Regulation & Policy
    Industry Assistance
    Key Statistics
    Table: Industry Data for the Intravenous (IV) Solution Manufacturing Industry
    Includes:
  • Industry Revenue (2007-2021)
  • Industry Gross Product (2007-2021)
  • Establishments (2007-2021)
  • Businesses (2007-2021)
  • Employment (2007-2021)
  • Exports (2007-2021)
  • Imports (2007-2021)
  • Wages (2007-2021)
  • Demand from hospitals (2007-2021)

  • Table: Annual Percentage Change for Key Industry Data
    Table: Key Ratios for Industry Key Data
    Jargon & Glossary
    Colloid
  • intravenous fluids that contain solutes in the form of large proteins or other similarly sized molecules.
  • Crystalloid
  • A solution of water with electrolytes; the most common type of IV solution.
  • Oxygen-Based Solution
  • A solution that consists of an artificially made red blood cell substitute whose main function is to carry oxygen.
  • Why buy this report?

    IBISWorld industry market research reports enable you to:
    • Find out about key industry trends
    • Identify threats and opportunities
    • Inform your decisions for marketing, strategy and planning
    • Quickly build competitive intelligence
    This report on Intravenous (IV) Solution Manufacturing:
    • Provides Market Size information to assist with planning and strategic decisions.
    • Includes the necessary information to perform SWOT, PEST and STEER analysis.
    • Helps you understand market dynamics to give you a deeper understanding of industry competition and the supply chain.
    • Analyses key performance and operational metrics so that you can benchmark against your own business, that of your customers’ businesses, or your competitors’ businesses.
    The Intravenous (IV) Solution Manufacturing market research report includes:
    • Historical data and analysis for the key drivers of this industry
    • A five-year forecast of the market and noted trends
    • Detailed research and segmentation for the main products and markets
    • An assessment of the competitive landscape and market shares for major companies
    • And of course, much more

    IBISWorld reports on thousands of industries around the world. Our clients rely on our information and data to stay up-to-date on industry trends across all industries. With this IBISWorld Industry Research Report on Intravenous (IV) Solution Manufacturing, you can expect thoroughly researched, reliable and current information that will help you to make faster, better business decisions.

    Join IBISWorld today

    Contact Us

    Want to speak to a representative? Call us.

    clear